Compare DGII & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DGII | ICUCW |
|---|---|---|
| Founded | 1985 | N/A |
| Country | United States | United States |
| Employees | 913 | 18 |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | N/A |
| IPO Year | N/A | 2021 |
| Metric | DGII | ICUCW |
|---|---|---|
| Price | $44.47 | $0.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $46.80 | N/A |
| AVG Volume (30 Days) | ★ 295.4K | N/A |
| Earning Date | 02-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.05 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $430,221,000.00 | N/A |
| Revenue This Year | $10.51 | N/A |
| Revenue Next Year | $8.01 | N/A |
| P/E Ratio | $41.19 | ★ N/A |
| Revenue Growth | ★ 1.46 | N/A |
| 52 Week Low | $22.39 | N/A |
| 52 Week High | $48.00 | N/A |
| Indicator | DGII | ICUCW |
|---|---|---|
| Relative Strength Index (RSI) | 58.39 | 39.98 |
| Support Level | $43.28 | $0.01 |
| Resistance Level | $44.59 | $0.01 |
| Average True Range (ATR) | 1.25 | 0.00 |
| MACD | -0.34 | 0.00 |
| Stochastic Oscillator | 24.15 | 49.09 |
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.